Predictive Oncology Inc.
Predictive Oncology Inc. (POAI) Stock Overview
Explore Predictive Oncology Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
1.7M
P/E Ratio
-0.02
EPS (TTM)
$-141.32
ROE
4.25%
POAI Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Predictive Oncology Inc. (POAI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 33.35, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $9.08.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.02 and a market capitalization of 1.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.